Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020 October 20, 2020 Read More
Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics October 7, 2020 Read More
Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples September 14, 2020 Read More
Meridian Bioscience to Present at the H. C. Wainright 22nd Annual Global Investment Conference August 31, 2020 Read More
Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance August 7, 2020 Read More
Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020 July 16, 2020 Read More
Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays July 13, 2020 Read More
Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference May 29, 2020 Read More
Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month May 26, 2020 Read More
